These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30132539)

  • 1. Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
    Ni B; Zhou D; Jing Y; Liu S
    Mol Med Rep; 2018 Oct; 18(4):3649-3656. PubMed ID: 30132539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
    Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
    Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway.
    Zhou D; Ding T; Ni B; Jing Y; Liu S
    Int J Mol Med; 2019 Aug; 44(2):405-416. PubMed ID: 31173173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
    Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
    Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats.
    Chen M; Wang M; Yang Q; Wang M; Wang Z; Zhu Y; Zhang Y; Wang C; Jia Y; Li Y; Wen A
    Int J Mol Med; 2016 Jun; 37(6):1501-10. PubMed ID: 27121241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
    Min J; Wei C
    Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats.
    He H; Yang X; Shi M; Zeng X; Yang J; Wu L; Li L
    J Pharm Pharmacol; 2008 Jan; 60(1):115-23. PubMed ID: 18088512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes.
    Liu SX; Zhang Y; Wang YF; Li XC; Xiang MX; Bian C; Chen P
    Int J Cardiol; 2012 Oct; 160(2):95-101. PubMed ID: 21497407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
    Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W
    Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.
    Yuan W; Yang D; Sun X; Liu W; Wang L; Li X; Man X; Fu Q
    Int J Clin Exp Pathol; 2014; 7(9):5772-81. PubMed ID: 25337218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulinastatin protects rats with myocardial infarction by activating Nrf2/NOS pathway.
    Wang S; Cheng ZY; Chen XJ; Xue HZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8990-8998. PubMed ID: 30575944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
    Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
    J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of the HIF-1α-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia-reperfusion injury.
    Ge C; Meng D; Peng Y; Huang P; Wang N; Zhou X; Chang D
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113097. PubMed ID: 39260311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.
    Ye J; Wang R; Wang M; Fu J; Zhang Q; Sun G; Sun X
    Oxid Med Cell Longev; 2021; 2021():6643615. PubMed ID: 34093960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
    Jin M; Sun CY; Zang BX
    Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
    Jin M; Wang L; Wu Y; Zang BX; Tan L
    Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A.
    Wang C; Huang Q; Wang C; Zhu X; Duan Y; Yuan S; Bai X
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):895-904. PubMed ID: 23933165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxysafflor Yellow A Reprograms TLR9 Signalling Pathway in Ischaemic Cortex after Cerebral Ischaemia and Reperfusion.
    Gong Z; Pan J; Li X; Wang H; He L; Peng Y
    CNS Neurol Disord Drug Targets; 2018; 17(5):370-382. PubMed ID: 29732997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats.
    Lian FZ; Cheng P; Ruan CS; Ling XX; Wang XY; Pan M; Chen ML; Shen AZ; Gao S
    Biomed Pharmacother; 2019 Sep; 117():109124. PubMed ID: 31228798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.